Login / Signup

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.

Qian ZhangPaul BastardZhiyong LiuJérémie Le PenMarcela Moncada-VelezJie ChenMasato OgishiIra K D SabliStephanie HodeibCecilia KorolJérémie RosainKaya BilguvarJunqiang YeAlexandre BolzeBenedetta BigioJean-Laurent CasanovaAndrés Augusto AriasQinhua ZhouYu ZhangFanny OnodiSarantis KorniotisLéa KarpfQuentin PhilippotMarwa ChbihiLucie Bonnet-MadinKarim DorghamNikaïa SmithWilliam M SchneiderBrandon S RazookyHans-Heinrich HoffmannEleftherios MichailidisLeen MoensJi Eun HanLazaro LorenzoLucy BizienPhilip MeadeAnna-Lena NeehusAileen Camille UgurbilAurélien CorneauGaspard KernerPeng ZhangFranck RapaportYoann SeeleuthnerJérémy ManryCecile MassonYohann SchmittAgatha SchlüterTom Le VoyerTaushif KhanJuan LiJacques FellayLucie RousselMohammad ShahrooeiMohammed F AlosaimiDavood MansouriHaya Al-SaudFahd Al-MullaFeras AlmourfiSaleh Zaid Al-MuhsenFahad AlsohimeSaeed H Al TurkiRana HasanatoDiederik van de BeekAndrea BiondiLaura Rachele BettiniMariella D'Angio'Bonfanti PaoloLuisa ImbertiAlessandra SottiniSimone PagheraEugenia Quiros-RoldanCamillo RossiAndrew J OlerMiranda F TompkinsCamille AlbaIsabelle VandernootJean-Christophe GoffardGuillaume SmitsIsabelle MigeotteFilomeen HaerynckPere Soler-PalacinAndrea Martin-NaldaRoger ColobranPierre-Emmanuel MorangeSevgi KelesFatma ÇölkesenTayfun OzcelikKadriye Kart YasarSevtap ŞenoğluSemsi Nur KarabelaCarlos FloresGiuseppe NovelliSami HraiechYacine Tandjaoui-LambiotteXavier DuvalCédric Laouénannull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullAndrew L SnowClifford L DalgardJoshua D MilnerDonald C VinhTrine Hyrup MogensenNico MarrAndrás N SpaanBertrand BoissonStéphanie Boisson-DupuisJacinta BustamanteAnne PuelMichael J CiancanelliIsabelle MeytsTom ManiatisVassili SoumelisAli AmaraMichel C NussenzweigAdolfo García-SastreFlorian KrammerAurora PujolDarragh DuffyRichard P LiftonShen-Ying ZhangGuy GorochovVivien BéziatEmmanuelle JouanguySancho-Shimizu VanessaCharles M RiceLaurent AbelLuigi Daniele NotarangeloAurélie CobatHelen C SuJean Laurent Casanova
Published in: Science (New York, N.Y.) (2020)
Clinical outcome upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ranges from silent infection to lethal coronavirus disease 2019 (COVID-19). We have found an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern Toll-like receptor 3 (TLR3)- and interferon regulatory factor 7 (IRF7)-dependent type I interferon (IFN) immunity to influenza virus in 659 patients with life-threatening COVID-19 pneumonia relative to 534 subjects with asymptomatic or benign infection. By testing these and other rare variants at these 13 loci, we experimentally defined LOF variants underlying autosomal-recessive or autosomal-dominant deficiencies in 23 patients (3.5%) 17 to 77 years of age. We show that human fibroblasts with mutations affecting this circuit are vulnerable to SARS-CoV-2. Inborn errors of TLR3- and IRF7-dependent type I IFN immunity can underlie life-threatening COVID-19 pneumonia in patients with no prior severe infection.
Keyphrases